US Broker Ratings

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL) operates in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $14.04 billion,..

Alkermes plc (ALKS) Stock Analysis: Exploring an 18% Potential Upside with a Solid Revenue Growth Story

Alkermes plc (NASDAQ: ALKS), an innovative player in the biopharmaceutical sector, presents an intriguing opportunity for investors with its current market position. Headquartered in Dublin, Ireland,..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a Healthcare Giant with 11.67% Upside Potential

Fresenius Medical Care AG (FMS), a key player in the healthcare sector, specializes in providing dialysis and related services across the globe. With a market cap..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 40.78% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a notable player in the biotechnology sector, focused on developing therapies for severe and rare diseases. With a market..

Ionis Pharmaceuticals (IONS) Stock Analysis: Evaluating a 44% Potential Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at the forefront of the biotechnology industry with its innovative RNA-targeted medicines. Headquartered in Carlsbad, California, this healthcare sector player..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility in Biotechnology with a Potential 22.73% Downside

For investors focusing on the dynamic biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) presents a compelling yet complex opportunity set against the backdrop of an ever-evolving healthcare..

Bausch + Lomb Corporation (BLCO) Stock Report: Analyzing a 9.10% Revenue Growth in the Healthcare Sector

Investors keeping a close eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect. As a key player in the..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Potential Upside Amidst Robust Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the Diagnostics & Research sector, commands attention with its robust $28.02 billion market capitalization. Operating from its..

Grifols, S.A. (GRFS) Stock Analysis: A Potential 41% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) presents a compelling investment opportunity in the healthcare sector, known for its robust portfolio of plasma-derived medicines. Headquartered in Barcelona, Spain, Grifols..

West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a formidable player in the healthcare sector, is capturing the attention of investors with its robust market presence and promising..

Doximity, Inc. (DOCS): Investor Outlook Reveals 11.40% Potential Upside Amidst Strong Market Dynamics

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, is capturing investor attention with its promising growth metrics and significant market presence...

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 6.41% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with a robust market capitalization of $35.16 billion. As a major player in the healthcare..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 29% Upside Potential

For investors eyeing the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents a compelling opportunity, with a notable potential upside of 29.22% based on the..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.36% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, is capturing investor attention with a market..

Universal Health Services, Inc. (UHS) Stock Analysis: Strong Revenue Growth and a 12.98% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $10.12 billion, this..

Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently capturing investor attention with its diverse product portfolio and a notable potential..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the medical distribution sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Market Challenges with Robust Revenue Growth

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to demonstrate resilience in the ever-evolving pharmaceutical landscape. With a market capitalization of $136..

Penumbra, Inc. (PEN) Stock Analysis: Unraveling the 12.48% Potential Upside

Penumbra, Inc. (NYSE: PEN) stands as a formidable player in the healthcare sector, specializing in the design, development, and marketing of innovative medical devices. With a..

Elanco Animal Health (ELAN) Stock Analysis: Unveiling a 29% Upside Potential Amidst Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector’s drug manufacturing niche, has caught the attention of investors with its compelling growth..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds